Breast cancer
Conditions
Interventions
Research Group (Endoscopic Group):Not mentioned
Control group (Open Group):Not mentioned
Sponsors
Department of Breast and Thyroid Surgery, the First Affiliated Hospital of Army Military Medical University (Southwest Hospital)
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) Age: 18 -70 years old; 2) Pathologically confirmed as invasive breast cancer; 3) T1-2N0M0 was unwilling to undergo breast-conserving surgery or T3N0M0 was evaluated by clinicians as still not suitable for breast-conserving surgery after neoadjuvant therapy; 4) Those with breast volume less than 500 ml and no severe ptosis; 5) No imaging or clinical evidence was found before the operation that the tumor invaded the nipples, areolas and subcutaneous tissues. 6) The preoperative ECOG physical condition score ranged from 0 to 1 point; 7) Preoperative ASA score I-III; 8) Undergo breast prosthesis reconstruction, agree to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Bilateral breast cancer or contralateral breast requires prophylactic resection; 2) Had received less than 4 cycles of non-standard comprehensive anti-tumor treatment before enrollment; 3) Severe dysfunction of important organs such as the heart, liver, lungs and kidneys, which cannot tolerate anesthesia, surgery and necessary comprehensive treatment; 4) History of malignant tumors, or other malignant tumors discovered through examination (excluding thyroid cancer, basal cell carcinoma of the skin, etc.); 5) The patient is currently or occasionally smoking; 6) After the clinical doctor made a detailed inquiry about the patient's past medical history and a comprehensive assessment, it was found that the patient suffered from a serious mental disorder and was unable to fully understand the research content and cooperate to complete the trial. 7) A history of unstable angina pectoris or myocardial infarction, cerebral infarction or cerebral hemorrhage within 6 months; 8) Concurrent major surgical treatment for other diseases is required; 9) Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical efficacy;Surgical safety; | — |
Countries
China
Contacts
Public ContactJiang Jun
Department of Breast and Thyroid Surgery, the First Affiliated Hospital of Army Military Medical University (Southwest Hospital)
Outcome results
None listed